This week in gene and cell therapy - 27 October 2017
Gene and cell therapy headlines 23 - 27 October
British healthcare cost agency NICE supports use of GSK's Strimvelis gene therapy for ASA-SCID
Oxford based company Genomics to work on treatments for MS with Biogen
New A -> T base editing enzyme extends potential correction of single base pair mutations
CRISPR based REPAIR system edits RNA
uniQure to start clinical trials for haemophilia B in 2018
Shire to start clinical trials for haemophilia A after being granted orphan drug designation by FDA
bluebird bio publishes first data from Starbeam trial of gene therapy for adrenoleukodystrophy